Michael J. Doyle
Direttore/Membro del Consiglio presso ICAD, INC.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Dana Brown | F | 59 | 2 anni | |
Miruna Sasu | M | - |
Cota, Inc.
Cota, Inc. Packaged SoftwareTechnology Services Cota, Inc. provides healthcare services. It specializes in healthcare information technology. The company was founded by Andrew L. Pecora in 2011 and is headquartered in New York, NY. | 3 anni |
Richard Sullivan | M | - |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | 16 anni |
Barry L. Johnson | M | - |
Windward Advisors LLC
Windward Advisors LLC Investment Banks/BrokersFinance Windward Advisors LLC operates as an investment banking firm. It offers mergers and acquisitions, lending, capital raising, buyer and seller representation, and corporate growth and business advisory services. The company was founded by Steven D. Howell and Barry L. Johnson in 2006 and is headquartered in Manakin Sabot, VA. | 18 anni |
Andrew Sassine | M | 59 | 9 anni | |
Eric Lonnqvist | M | 49 | 3 anni | |
Susan Wood | M | 60 | 6 anni | |
Steven D. Howell | M | - |
Windward Advisors LLC
Windward Advisors LLC Investment Banks/BrokersFinance Windward Advisors LLC operates as an investment banking firm. It offers mergers and acquisitions, lending, capital raising, buyer and seller representation, and corporate growth and business advisory services. The company was founded by Steven D. Howell and Barry L. Johnson in 2006 and is headquartered in Manakin Sabot, VA. | 18 anni |
Rakesh Patel | M | 50 | 6 anni | |
Neema Moraveji | M | - |
Spire, Inc. (California)
Spire, Inc. (California) Specialty StoresRetail Trade Spire, Inc. develops respiration tracker device. It offers Spire application that classifies breathing patterns based on dozens of laboratory studies correlating respiration patterns with cognitive and emotional state. The company was founded by Jonathan Palle, Diego Prats and Neema Moraveji on May 4, 2012 and is headquartered in San Francisco, CA. | 12 anni |
Brian Testa | M | - | 3 anni | |
William Keyes | M | - | 1 anni | |
Michael Mitchell | M | - |
Cota, Inc.
Cota, Inc. Packaged SoftwareTechnology Services Cota, Inc. provides healthcare services. It specializes in healthcare information technology. The company was founded by Andrew L. Pecora in 2011 and is headquartered in New York, NY. | 3 anni |
Vasu Avadhanula | M | - | 1 anni | |
Michelle Strong | F | - | 1 anni | |
Philippe Chambon | M | 65 |
Qpid Health, Inc.
Qpid Health, Inc. Packaged SoftwareTechnology Services Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA. | 10 anni |
Doug Keare | M | - |
Spire, Inc. (California)
Spire, Inc. (California) Specialty StoresRetail Trade Spire, Inc. develops respiration tracker device. It offers Spire application that classifies breathing patterns based on dozens of laboratory studies correlating respiration patterns with cognitive and emotional state. The company was founded by Jonathan Palle, Diego Prats and Neema Moraveji on May 4, 2012 and is headquartered in San Francisco, CA. | - |
Hedvig Hricak | M | 77 | - | |
Jonathan Go | M | 59 | 18 anni | |
J. White | M | - |
AdvantEdge Healthcare Solutions, Inc.
AdvantEdge Healthcare Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services AdvantEdge Healthcare Solutions, Inc. provides medical billing and practice management services. It serves specialty physicians, surgery centers, medical billing companies, and hospitals. The firm offers billing, coding, pricing, performance, reporting and dashboards, compliance and consulting solutions. The company was founded in 1999 and is headquartered in Warren, NJ. | 18 anni |
Bill Keyes | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
James Manuso | M | 75 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 7 anni |
Joanne M. Protano | F | 55 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 8 anni |
John Hervey | M | - |
Cota, Inc.
Cota, Inc. Packaged SoftwareTechnology Services Cota, Inc. provides healthcare services. It specializes in healthcare information technology. The company was founded by Andrew L. Pecora in 2011 and is headquartered in New York, NY. | 5 anni |
Michael Gosman | M | 61 |
CareMatrix Corp.
CareMatrix Corp. Medical/Nursing ServicesHealth Services CareMatrix Corp. provides assisted living and other long-term care services. The company's strategy is to provide a full range of assisted living and other long-term care and related services across a range of pricing options. The company was founded in October 1989 and is headquartered in Newton, MA. | 3 anni |
Kristin C. Schuhwerk | F | 53 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 5 anni |
John Niederhuber | M | 85 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 anni |
Thomas Mackie | M | 69 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 anni |
Stephen Hill | M | 65 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 7 anni |
John Neis | M | 68 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 anni |
Michael F. Tweedle | M | 73 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 anni |
Jamey P. Weichert | M | 67 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 anni |
Elias B. Nyberg | M | - |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | - |
John T. Bright | M | - |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | - |
Caroline Smyth | F | - |
Qpid Health, Inc.
Qpid Health, Inc. Packaged SoftwareTechnology Services Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA. | - |
Doug Schumann | M | - |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | - |
Michael Previti | M | - |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | - |
Thomas J. May | M | - | 5 anni | |
Kathy Doub English | F | - |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | 2 anni |
Nancy Ellen Freeman | F | - | 2 anni | |
Carl Berke | M | - |
Qpid Health, Inc.
Qpid Health, Inc. Packaged SoftwareTechnology Services Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA. | 4 anni |
Richard G. Jung | M | - |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | - |
John Wagner | M | 50 |
Salesnet, Inc.
Salesnet, Inc. Packaged SoftwareTechnology Services Salesnet, Inc. was a provider of online CRM software specializing in managing and reinforcing sales processes. It was committed to bettering sales teams in aspiring organizations by providing online sales solution that integrates organization's practices and methodologies to improve the efficiency, effectiveness and profitability of each individual sales professional. Organizations such as American Express Incentive Services, Sovereign Bank, JetBlue, GreenPages, and Tellabs used to use the company's software to improve the efficiency, effectiveness and profitability of global sales organizations. The company was founded by Richard Perkett in 1997 and is headquartered in Boston, MA. | 3 anni |
Robert M. Kaufman | M | 74 |
CareMatrix Corp.
CareMatrix Corp. Medical/Nursing ServicesHealth Services CareMatrix Corp. provides assisted living and other long-term care services. The company's strategy is to provide a full range of assisted living and other long-term care and related services across a range of pricing options. The company was founded in October 1989 and is headquartered in Newton, MA. | 3 anni |
Larry Humphrey | M | - | 9 anni | |
Kimberly A. Hawkins | F | 51 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 7 anni |
Simyon S. Palmin | M | 79 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 12 anni |
M. Taylor Burtis | F | 72 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 3 anni |
John R. Wetherell | M | - | 8 anni | |
Sim Fass | M | 82 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 6 anni |
David McWilliams | M | 80 |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | 6 anni |
Michael J. Shannahan | M | 75 |
Medsphere Systems Corp.
Medsphere Systems Corp. Information Technology ServicesTechnology Services Medsphere Systems Corp. engages in the provision of healthcare information technology platform solutions and services. It offers hospital EHR, rev cycle management, physician practice EHR, supply chain MGMT, weelsoft EDIS, and phoenix IT services.. The company was founded by Steven G. Shreeve and Scott Shreeve in 2002 and is headquartered in Carlsbad, CA. | 3 anni |
Matt Gibbons | M | - |
Cota, Inc.
Cota, Inc. Packaged SoftwareTechnology Services Cota, Inc. provides healthcare services. It specializes in healthcare information technology. The company was founded by Andrew L. Pecora in 2011 and is headquartered in New York, NY. | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 53 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael J. Doyle
- Contatti personali